Investment
Features
FeesSafety
Academy
More
Pluang+

Compare YieldMax MSTR Option Income Strategy ETF (MSTY) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

YieldMax MSTR Option Income Strategy ETFTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

YieldMax MSTR Option Income Strategy ETF vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? YieldMax MSTR Option Income Strategy ETF trades at $14.1 (market cap $1.14B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 9.5× YieldMax MSTR Option Income Strategy ETF's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while YieldMax MSTR Option Income Strategy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax MSTR Option Income Strategy ETF for 31 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

MSTYRDY
Market Cap
$1.14B$10.78B
Volume
1,611,7832,724,343
Sector
Income / Options OverlayHealth
52-Week High
$63.60$15.38
52-Week Low
$11.55$11.38
Typical Hold Time
31 Days0 Days
Enterprise Value
—$10.68B
Dividend Yield
—0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

YieldMax MSTR Option Income Strategy ETF

MSTY trades at $15.52, down 0.13% on the day, with a bearish technical outlook as moving averages signal selling pressure. The ETF's high distribution rate, exceeding 100% annualized, is a key feature but has coincided with significant NAV erosion, as noted in recent financial media. Recent weekly dividend announcements from YieldMax highlight the income focus, but underlying asset volatility remains a concern.

The outlook is cautious; while the high yield is attractive for income-seeking investors, it comes with substantial risk of principal depletion. Analyst sentiment is mixed, balancing the tactical income opportunity against structural concerns about the fund's long-term sustainability in volatile markets.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MSTY
95% Buy5% Sell
Avg holding period · 31 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

About YieldMax MSTR Option Income Strategy ETF

MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.

Read more on MSTY →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →